[Drug therapy regimens in diabetic retinopathy]

Diabetes mellitus constitutes the fourth cause of general mortality and diabetic retinopathy, one of the most important cause of blindness. The paper shows the necessity and the possibilities of the most precocious treatment of diabetic retinopathy, depending of the complex pathogenesis of the disease, as well as the necessity of the new clinical and pharmacological trials for certify its effects.